Effects Of Ballistic Six Exercises Versus Resistance-Band Exercises On Physical Performance Of Tennis Players

December 20, 2024 updated by: Riphah International University
A randomized clinical trial will be conducted at Ghakhar Sports Complex,Gujranwala. Twenty eight subjects of both genders aged between 18 to 30 years will be selected who have been playing tennis for more than a year. Subjects will be randomized into two groups; Ballistic six exercises will be given to group A and exercises of 3 sets of 10-20 repetitions will be completed, with each series offering 30-60 seconds of rest. The ballistic Six exercise uses resistance-band latex tube and fitness balls. Resistance-band exercises will be given to group B and the duration of training sessions will be 3 sets of 10-20 repetitions.Assessments done will be sitting medicine ball throw test (SMBT) for shoulder strength, closed kinetic chain upper extremity stability test (CKUCEST) for agility, plate tapping test (PTT) for speed and kerlan jobe Orthopedic Clinical Score (KJOC) for shoulder function. Assessment will be done at baseline, post 8 weeks of training, at the end of 6 months. Data will be analyzed using SPSS software version 21.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

During regular training, players sustain injuries on a regular basis. Based on the fact that tennis isn't seen at all as a contact sport the majority of injuries are caused by overuse. A participant must perform a variety of quick, yet repeated shoulder action and repetitive motions put tension mostly on tissues with time, putting them at risk of damage. Current study will be done to compare the effects of ballistic six training versus resistance-band exercises on shoulder strength, agility, speed, and function in transitional tennis players.

A randomized clinical trial will be conducted at Ghakhar Sports Complex,Gujranwala. Twenty eight subjects of both genders aged between 18 to 30 years will be selected who have been playing tennis for more than a year. Subjects will be randomized into two groups; Ballistic six exercises will be given to group A and exercises of 3 sets of 10-20 repetitions will be completed, with each series offering 30-60 seconds of rest. The ballistic Six exercise uses resistance-band latex tube and fitness balls. Resistance-band exercises will be given to group B and the duration of training sessions will be 3 sets of 10-20 repetitions.Assessments done will be sitting medicine ball throw test (SMBT) for shoulder strength, closed kinetic chain upper extremity stability test (CKUCEST) for agility, plate tapping test (PTT) for speed and kerlan jobe Orthopedic Clinical Score (KJOC) for shoulder function. Assessment will be done at baseline, post 8 weeks of training. Data will be analyzed using SPSS software version 21. Normality of data will be checked, and tests will be applied according to normality of the data, either parametric or non-parametric test will be used (within a group or between two groups).

Key words: Agility, Ballistic Six Exercises, closed kinetic chain upper extremity stability test (CKUCEST), Fitness ball, Kerlan jobe Orthopedic Clinical score (KJOC), Plate tapping test (PTT), Resistance band exercises.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
32

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Gujrānwāla, Punjab, Pakistan
        • Ghakhar Sports Complex

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age between 18-30 years
  • Participants with minimum of 1 year of tennis playing experience and normal BMI.
  • Both Male and Female participants
  • Participants willing to provide informed consent for participation.

Exclusion Criteria:

  • Participants with less than 1 year of playing experience
  • Participants who had history of bone or joint disease, musculoskeletal or painful condition (such as Carpal tunnel syndrome, Tennis elbow injury)
  • History of neurological impairment, suffering from back pain for span of month
  • Not willing to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: BALLISTIC SIX EXERCISES
The Ballistic Six exercise uses resistance-band latex tube (red) and fitness balls (2-lb for one extremity training / 6-lb for dual extremity training). The 6 exercises includes; External rotation with latex tube, 90/90 external rotation with latex tube, overhead soccer throws using a fitness ball, 90/90 external rotation side-throw using a fitness ball, deceleration baseball throws using a fitness ball and baseball throws using a medicine ball
Other: BALLISTIC SIX EXERCISES
Ballistic six exercises will be given to group A and exercises of 3 sets of 10-20 repetitions will be completed, with each series offering 30-60 seconds of rest. The ballistic Six exercise uses resistance-band latex tube and fitness balls.
Experimental: RESISTANCE-BAND EXERCISES
Week wise resistance-band training includes; 1-4 weeks: Standing Shoulder Press, Chest Fly, Triceps French Press, Biceps Curl, Rhomboid Squeeze, 5-6 weeks: Trunk Twist, Reverse Flies, Concentration Curl Scapular, Retraction, 7-8 weeks: Straight Arm Pull down, Chest Press, Triceps Kick Back, Rear Deltoid, Dead Lift
Other: RESISTANCE-BAND EXERCISES
Resistance-band exercises will be given to group B and the duration of training sessions will be 3 sets of 10-20 repetitions

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Sitting medicine ball throw test
Time Frame: Assessment will be done at baseline, post 8 weeks of training
Sitting Medicine Ball Throw Test (SMBT) for shoulder strength
Assessment will be done at baseline, post 8 weeks of training
Closed kinetic chain upper extremity stability test
Time Frame: Assessment will be done at baseline, post 8 weeks of training
Closed Kinetic Chain Upper Extremity Stability Test (CKUCEST) for agility
Assessment will be done at baseline, post 8 weeks of training
Plate tapping test
Time Frame: Assessment will be done at baseline, post 8 weeks of training
Plate tapping test (PTT) for speed
Assessment will be done at baseline, post 8 weeks of training
Kerlan Jobe Orthopedic Clinical Score
Time Frame: Assessment will be done at baseline, post 8 weeks of training
Kerlan Jobe Orthopedic Clinical Score (KJOC) for shoulder function
Assessment will be done at baseline, post 8 weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Amna Shahid, MS-DP, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 24, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 25, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
December 20, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 20, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 20, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCR&AHS/24/0434

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings